2025 Annual Performance Report of Independent Director
Tianwei Vision: 2025 Annual Performance Report of Independent Director
To all shareholders and shareholder representatives:
As an independent director of Tianwei Vision Co., Ltd. (hereinafter referred to as the "Company"), in 2025, I, in accordance with the "Company Law of the People's Republic of China," the "Administrative Measures for Independent Directors of Listed Companies," the "Shenzhen Stock Exchange Main Board Listed Company Self-Regulatory Management Guide No. 1 - Standardized Operation of Main Board Listed Companies," and other relevant laws and regulations, as well as the Company's "Articles of Association" and "Work System for Independent Directors," attended Company board meetings and shareholder meetings. I faithfully and diligently performed my duties as an independent director, safeguarding the vital interests of the Company and its shareholders, especially small and medium shareholders. Herein is a report of my performance in 2025:
I. Basic Information of Independent Directors
(I) Basic Information
Ms. Bi Xiaoting: Born in July 1981, with a bachelor's degree, and a lawyer. She previously served as an independent director of Yiatong Supply Chain Co., Ltd. She is currently an independent director of this Company, a lawyer in the Securities Department of Deheng Law Firm (Shenzhen), and concurrently serves as an independent director of Defang Nano Technology Co., Ltd.
(II) Statement on Circumstances Affecting Independence
As an independent director of the Company, after self-examination, I confirm that I meet the requirements of relevant laws and regulations, including the "Administrative Measures for Independent Directors of Listed Companies" and the "Shenzhen Stock Exchange Main Board Listed Company Self-Regulatory Management Guide No. 1 - Standardized Operation of Main Board Listed Companies," regarding the independence of independent directors. There are no circumstances affecting my independence.
II. Attendance at Board and Shareholder Meetings and Voting in 2025
The Company held 9 board meetings in 2025. My attendance is as follows:
| Meeting Type | Number of Meetings to Attend | Number of On-site Attendance | Number of Attendance via Communication | Number of Proxy Attendance | Number of Absences |
|---|---|---|---|---|---|
| Board Meeting | 9 | 2 | 7 | 0 | 0 |
The Company held 3 shareholder meetings in 2025. My attendance is as follows:
| Meeting Type | Number of Shareholder Meetings Held | Number of On-site Attendance |
|---|---|---|
| Shareholder Meeting | 3 | 1 |
During my term as an independent director of Tianwei Vision Co., Ltd. in 2025, I was required to attend 9 board meetings, all of which I attended in person after carefully reviewing the agenda items. I was also required to attend 3 shareholder meetings, of which I attended 1 in person. I was unable to attend 2 board meetings due to work commitments. I voted in favor of all proposals at the board meetings I attended, with no opposing or abstaining votes.
III. Attendance and Performance in Board Special Committees and Independent Director Meetings
I serve as a member of the Ninth Board's Remuneration and Nomination Committee and the Ninth Board's Nomination Committee. In 2025, I attended 1 remuneration and nomination committee meeting and 4 nomination committee meetings. The details are as follows:
(I) Performance in the Remuneration and Nomination Committee
On April 3, 2025, the Ninth Board's Remuneration and Nomination Committee held its second meeting via communication. The committee members reviewed and approved the "Proposal on Reviewing the Remuneration of Directors, Supervisors, and Senior Management for 2024," which was submitted to the board for deliberation.
(II) Performance in the Nomination Committee
- On March 18, 2025, the Ninth Board's Nomination Committee held its second meeting via communication. The committee members reviewed and approved the "Proposal on Nominating the Deputy General Manager," agreeing to nominate Mr. Wang Ding for the position of Deputy General Manager and submitting it to the board for deliberation.